Studying a catalyst for blood cancers
Tuesday, April 25, 2017 - 09:02
in Health & Medicine
A new paper describes how TET2 loss can open the door for mutations that drive myeloid, lymphoid, and other cancers.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via